Gonadal Hormones and Bone
- 10 December 2019
- book chapter
- Published by Springer Nature
- p. 65-91
Abstract
In both sexes, estrogen is one of the most essential hormones for maintaining bone integrity. Also, especially in men, androgen has beneficial effects on bone independent of estrogen. However, estrogen replacement therapy for postmenopausal women increases the risk of developing breast cancer and endometrial cancer, and androgen replacement therapy for partial androgen deficiency of the aging male increases the risk of developing prostate cancer. Various mechanisms have been proposed on the effects of gonadal hormones on bone, such as effects through cytokines including IL-6 and effects on the OPG/RANKL ratio. In addition, large amounts of new information deriving from high-throughput gene expression analysis raise the possibility of multiple other effects on bone cells. Both estrogen and androgen exert their effects via the estrogen receptor (ER) or the androgen receptor (AR), which belongs to the nuclear receptor superfamily. Compounds such as selective estrogen receptor modulators (SERMs) and selective androgen receptor modulators (SARMs) also bind ER and AR, respectively. However, SERMs and SARMs alter the ER or AR structure differently from estrogen or androgen, resulting in other downstream gene responses. As a result they can exert favorable effects on bone while suppressing the undesirable actions of estrogen and androgen. Elucidation of ER and AR ligand-specific and tissue-specific gene regulation mechanisms will also provide information on the signal transduction mechanisms of other nuclear receptors and will be valuable for the development of new therapeutic agents.Keywords
This publication has 160 references indexed in Scilit:
- Distinct effects of loss of classical estrogen receptor signaling versus complete deletion of estrogen receptor alpha on boneBone, 2011
- Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled studyOsteoporosis International, 2011
- Direct transcriptional targets of sex steroid hormones in boneJournal of Cellular Biochemistry, 2010
- Effects of chronic estrogen treatment on modulating age-related bone loss in female miceJournal of Bone and Mineral Research, 2010
- Signaling pathways implicated in androgen regulation of endocortical boneBone, 2010
- Targeting of androgen receptor in bone reveals a lack of androgen anabolic action and inhibition of osteogenesisBone, 2008
- New insights into the classical and non-classical actions of estrogen: Evidence from estrogen receptor knock-out and knock-in miceMolecular and Cellular Endocrinology, 2008
- Selective Androgen Receptor Modulator (SARM) Treatment Prevents Bone Loss and Reduces Body Fat in Ovariectomized RatsPharmaceutical Research, 2006
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- ERβ: Identification and characterization of a novel human estrogen receptorFEBS Letters, 1996